Vision Shopsters: UK Pharmaceutical Market Overview - Pricing and reimbursement challenges dampen future growth

Introduction

Introduction

The UK prescription pharmaceutical market was valued at $28.4 billion in 2009. Key growth drivers include growing use of chronic high-value innovative treatments driven by a rising elderly population, high public healthcare expenditure as proportion of total healthcare expenditure, relatively light pricing controls through the PPRS, and speedy domestic drug approvals.

Scope

*Overview of the UK's socioeconomic and demographic trends, healthcare system, regulation, pricing and reimbursement and intellectual property position

*Assesses the size of the UK's pharmaceutical market by prescribing setting, therapy area, leading brands and by leading companies

*Examines the UK's generics and biosimilars landscape in terms of regulatory issues, level of penetration, key players and degree of brand erosion

*Quantifies the UK's R&D and manufacturing infrastructure for the leading pharmaceutical companies, including key metrics and domestic M&A analysis.

Highlights

The UK pharmaceutical industry has to some extent been cushioned from the effects of the recession. However, the NHS now faces cuts and with price cuts to be implemented in Southern Europe further stimulating the parallel exportation of drugs out of these markets, branded drug sales in the UK market will certainly be impacted.

The UK's Department of Health is considering imposing mandatory generic substitution at the pharmacist level, as part of the renegotiated PPRS which came into effect in 2009. Mandatory substitution should boost generics volume uptake in the UK, but the extent of the increase is likely to be limited, given the widespread use of generics in the UK.

The UK has a strong track record for drug development. However, Roche and Novartis have threatened to pull out of the UK due to ongoing debates over drug pricing, expensive and bureaucratic clinical trials, and recent non-approval decisions by NICE. Also, a number of key players are downsizing their UK operations in an effort to reduce costs.

Reasons to Purchase

*Evaluate the evolving regulatory landscape and the impact of pricing and reimbursement controls on market access.

*Quantify the size and growth of the prescription pharmaceutical market in the UK, analyzing key therapy areas, brands and companies.

*Assess drivers and resistors of generic and biosimilars uptake in the UK as well as the level of erosion brands can expect to face post patent expiry.

Table Of Contents :

ABOUT DATAMONITOR HEALTHCARE 2

About the Healthcare Strategic Analysis Team 2

Country specific reports: 2

Global issue reports: 2

1. Executive Summary 3

Strategic scoping and focus 3

Key findings - UK healthcare drivers and resistors 4

Socio-demographic and economic analysis 8

UK socio-demographic trends 8

UK socio-economic trends 8

Healthcare system and drug regulatory analysis 10

UK healthcare expenditure 10

UK healthcare system overview 11

UK regulatory issues 11

UK pricing and reimbursement issues 11

Prescription pharmaceutical sales analysis 13

UK pharmaceutical market size 13

UK leading therapy areas 13

UK leading prescription pharmaceutical brands 13

UK pharmaceutical companies 13

Drug expiry analysis 15

UK generics market 15

UK brand erosion post patent expiry 15

UK biosimilars market 15

Pharmaceutical industry infrastructure analysis 17

UK pharmaceutical industry infrastructure overview 17

UK R&D infrastructure trends 17

UK manufacturing infrastructure trends 18

Related reports 20

Upcoming related reports 20

Table of Contents 21

2. Socio-demographic and economic analysis 22

To know more about this report & to buy a copy please visit :

http://www.visionshopsters.com/product/4595/UK-Pharmaceutical-Market-Overview-Pricing-and-reimbursement-challenges-dampen-future-growth.html

Vision Shopsters: UK Pharmaceutical Market Overview - Pricing and reimbursement challenges dampen future growth

By: Vision Shopsters

POST COMMENT

Car Aftermarket in the UK Country Overviews 2010 - Market Research Report On Aarkstore Enterprise Aarkstore Enterprise - Urinary Incontinence - Pipeline Assessment and Market Forecasts to 2017 Domain Marketing Tips Aarkstore Enterprise - Womens Infertility - Pipeline Assessment and Market Forecasts to 2017 EMEA Logistics and Express Market Overview - Market Research Report On Aarkstore Enterprise Stock Market and Painful Investment in Nepal Aarkstore enterprise-- Global Magnetic Resonance Imaging (MRI) Systems Market, 2010 - 2015 The Basics of Email Marketing Airlines: Advanced Emerging Markets (Brazil, Hungary, Mexico, Poland, South Africa, Taiwan) Industry Guide Aarkstore enterprise--- Global Magnetic Resonance Imaging (MRI) Systems Market, 2010 - 2015 Profits for everyone from Forex market… 2 Basic Tips To Avoid an Investment Scam My Shed Plans Scam